Astera Labs, Inc. (ALAB) AI Stock Analysis
Astera Labs, Inc.
(BMV:ALAB)
No summary available
Astera Labs, Inc. (ALAB) vs. SPDR S&P 500 ETF (SPY)
- Market Cap
- MXN 44.88B
- Dividend Yield
- ―
- Average Volume (3M)
- 642
- Price to Earnings (P/E)
- 119.2
- Beta (1Y)
- 0.48
- Revenue Growth
- 79.41%
- EPS Growth
- 217.94%
- Country
- Mexico
- Employees
- 756
- Sector
- Technology
- Sector Strength
- 61
- Industry
- Semiconductors
Astera Labs, Inc. Business Overview & Revenue Model
Company Description
Astera Labs, Inc. develops, produces, and markets semiconductor-based connectivity solutions for cloud computing and artificial intelligence infrastructure. Its core offering, the Intelligent Connectivity Platform, comprises a comprehensive portfolio...
Astera Labs, Inc. Earnings Call Summary
The call presents a strongly positive operational and financial picture: record revenue, rapid transition to PCIe 6, Scorpio X entering volume production ahead of schedule, record Aries performance, meaningful product-roadmap expansion (CXL, optics), and robust profitability and cash. The primary concerns are execution and concentration risk around the Scorpio ramp, elevated near-term operating expenses, and margin variability driven by product mix. Overall, the highlights materially outweigh the lowlights.
Q2-2026 Updates
Positive Updates
Negative Updates
Company Guidance
Management guided Q3 non‑GAAP revenue of $540–$560 million (midpoint implying roughly 40% sequential growth from Q2’s $392.4M) and said Scorpio will become the largest product family as Scorpio X moves to volume production. They expect Q3 non‑GAAP gross margin of ~72% (Q2 was 73.7%), non‑GAAP operating expenses of $156–160M, non‑GAAP operating margin of ~43% (up ~400 bps sequentially), interest & other income of ~$12M, a non‑GAAP tax rate of ~12%, diluted share count of ~185M, and non‑GAAP diluted EPS of $1.16–$1.21. Management also highlighted $1.25B of cash on hand and said the guidance is driven by the Scorpio X ramp, continued Aries PCIe‑6 strength, and pre‑production Taurus 100G/lane shipments.
Astera Labs, Inc. Risk Analysis
Astera Labs, Inc. disclosed 64 risk factors in its most recent earnings report. Astera Labs, Inc. reported the most risks in the "Finance & Corporate" category.
Latest Risks Added
0 New RisksAstera Labs, Inc. Peers Comparison
Overall Rating
AVGO74Outperform
CRDO73Outperform
MTSI72Outperform
MRVL70Outperform
MCHP63.4Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| 74Outperform | $1.56T | 40.46 | 43.91% | 0.80% | 48.69% | 99.97% | |
| 73Outperform | $28.38B | 51.18 | 27.16% | ― | 165.11% | 301.97% | |
| 72Outperform | $17.90B | 73.25 | 17.09% | ― | 28.36% | ― | |
| 70Outperform | $172.22B | 64.41 | 16.22% | 0.12% | 30.62% | ― | |
| 63Neutral | $42.00B | 107.16 | 6.90% | 2.35% | 20.93% | ― | |
| Sector * | 61Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% |
* Technology Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| MX:ALAB | Astera Labs, Inc. | 4783.00 | 1236.00 | 34.85% | |
| AVGO | Broadcom Inc. | 326.08 | -33.79 | -9.39% | |
| MTSI | Macom Technology Solutions | 234.39 | 84.20 | 56.06% | |
| MRVL | Marvell Technology Group | 196.40 | 106.18 | 117.70% | |
| MCHP | Microchip Technology | 77.34 | 16.52 | 27.17% | |
| CRDO | Credo Technology Group Holding Ltd. | 150.99 | -29.65 | -16.41% |
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.